HIGHLIGHTS
- who: Prasad Narayanan and colleagues from the Cytecare Cancer Hospitals, Yelahanka, Bengaluru, Karnataka, India have published the paper: Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Sarcoma: A Multicenter, Retrospective Study, in the Journal: Sarcoma 80 of 15/Nov/2019
- what: The authors report here a multicenter, retrospective experience in real-life practice evaluating the effectiveness and tolerability of NDLS in the treatment of sarcomas.
- how: Survival data were analyzed using a nonparametric procedure which performed PROC LIFETEST of SAS (version 9.4) to measure the duration of time until . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.